• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

散发性原发性甲状旁腺功能亢进症

Sporadic Primary Hyperparathyroidism.

作者信息

Kim Stephanie J, Shoback Dolores M

机构信息

Division of Endocrinology and Metabolism, University of California, 400 Parnassus Avenue A549, San Francisco, CA 94143, USA.

Endocrine Research Unit - 111N, San Francisco Department of Veterans Affairs Medical Center, Division of Endocrinology and Metabolism, San Francisco VA Medical Center, University of California, 1700 Owens Street, 3rd floor Room 369, San Francisco, CA 94158, USA.

出版信息

Endocrinol Metab Clin North Am. 2021 Dec;50(4):609-628. doi: 10.1016/j.ecl.2021.07.006.

DOI:10.1016/j.ecl.2021.07.006
PMID:34774237
Abstract

Sporadic primary hyperparathyroidism is a common endocrinopathy, particularly afflicting postmenopausal women and both African American men and women. Although classic signs and symptoms of the disease are well appreciated and described, because of the ease and availability and low threshold for screening, the disorder often is diagnosed in patients who are minimally symptomatic or asymptomatic. Surgery conducted by experienced endocrine surgeons has a high cure rate, particularly if guided by concordant imaging. In patients who cannot safely undergo surgery or who fail to be cured, medical therapy with the oral calcimimetic cinacalcet is a validated option for controlling serum calcium levels.

摘要

散发性原发性甲状旁腺功能亢进是一种常见的内分泌疾病,尤其好发于绝经后女性以及非裔美国男性和女性。尽管该疾病的典型体征和症状已广为人知并得到描述,但由于筛查操作简便、可及性高且阈值低,该疾病常在症状轻微或无症状的患者中被诊断出来。由经验丰富的内分泌外科医生进行手术,治愈率很高,特别是在影像学检查的协同引导下。对于无法安全接受手术或手术未能治愈的患者,口服拟钙剂西那卡塞进行药物治疗是控制血清钙水平的有效选择。

相似文献

1
Sporadic Primary Hyperparathyroidism.散发性原发性甲状旁腺功能亢进症
Endocrinol Metab Clin North Am. 2021 Dec;50(4):609-628. doi: 10.1016/j.ecl.2021.07.006.
2
Primary hyperparathyroidism.原发性甲状旁腺功能亢进症。
Med Clin (Barc). 2018 Mar 23;150(6):226-232. doi: 10.1016/j.medcli.2017.07.020. Epub 2017 Oct 6.
3
Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1).西那卡塞治疗与1型多发性内分泌肿瘤综合征(MEN1)相关的原发性甲状旁腺功能亢进患者。
Endocrine. 2016 Jun;52(3):495-506. doi: 10.1007/s12020-015-0696-5. Epub 2015 Jul 30.
4
Cinacalcet-Associated Resolution of Primary Hyperparathyroidism in a Patient With Normal Kidney Function.西那卡塞相关的肾功能正常患者原发性甲状旁腺功能亢进症的缓解。
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620936836. doi: 10.1177/2324709620936836.
5
Reduction in parathyroid adenomas by cinacalcet therapy in patients with primary hyperparathyroidism.西那卡塞治疗原发性甲状旁腺功能亢进症患者甲状旁腺瘤的减少。
J Bone Miner Metab. 2021 Jul;39(4):583-588. doi: 10.1007/s00774-020-01190-2. Epub 2021 Jan 6.
6
Effect of Cinacalcet in Kidney Transplant Patients With Hyperparathyroidism.西那卡塞对肾移植甲状旁腺功能亢进患者的影响。
Transplant Proc. 2019 Jun;51(5):1397-1401. doi: 10.1016/j.transproceed.2019.01.141.
7
Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis.西那卡塞用于治疗一名肝硬化患者的原发性甲状旁腺功能亢进引起的高钙血症。
Exp Clin Endocrinol Diabetes. 2009 Mar;117(3):142-5. doi: 10.1055/s-2008-1078741. Epub 2008 Jun 17.
8
Short-term medical treatment of hypercalcaemia in primary hyperparathyroidism predicts symptomatic response after parathyroidectomy.原发性甲状旁腺功能亢进症高钙血症的短期治疗可预测甲状旁腺切除术后的症状反应。
Br J Surg. 2019 Dec;106(13):1810-1818. doi: 10.1002/bjs.11319. Epub 2019 Oct 9.
9
Persistent hypercalcemia after parathyroidectomy in an adolescent and effect of treatment with cinacalcet HCl.一名青少年甲状旁腺切除术后持续性高钙血症及盐酸西那卡塞治疗效果
Clin Chem. 2006 Dec;52(12):2286-93. doi: 10.1373/clinchem.2006.070219. Epub 2006 Nov 14.
10
Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.盐酸西那卡塞在1型多发性内分泌腺瘤病原发性甲状旁腺功能亢进临床管理中的作用
Minerva Endocrinol. 2013 Dec;38(4):389-94.

引用本文的文献

1
The impact of body mass index on the diagnostic and surgical outcomes in primary hyperparathyroidism.体重指数对原发性甲状旁腺功能亢进症诊断及手术结果的影响。
Rev Assoc Med Bras (1992). 2025 May 2;71(3):e20240989. doi: 10.1590/1806-9282.20240989. eCollection 2025.
2
How has the diagnostic approach to parathyroid localization techniques evolved in the past decade? Insights from a single-center experience.在过去十年中,甲状旁腺定位技术的诊断方法是如何演变的?来自单中心经验的见解。
Updates Surg. 2025 Apr;77(2):389-399. doi: 10.1007/s13304-025-02090-8. Epub 2025 Jan 16.
3
Brown Tumors: The Hidden Face of Primary and Renal Hyperparathyroidism Amid Real-Life Settings.
棕色瘤:现实环境中原发性和肾性甲状旁腺功能亢进的隐匿面貌。
J Clin Med. 2024 Jun 29;13(13):3847. doi: 10.3390/jcm13133847.
4
Secular trends in the incidence and treatment patterns of primary hyperparathyroidism in Korea: a nationwide cohort study.韩国原发性甲状旁腺功能亢进症发病率及治疗模式的长期趋势:一项全国性队列研究
JBMR Plus. 2024 May 13;8(7):ziae065. doi: 10.1093/jbmrpl/ziae065. eCollection 2024 Jul.
5
Delayed Diagnosis of Primary Hyperparathyroidism: A Case Report.原发性甲状旁腺功能亢进症的延迟诊断:一例报告
Cureus. 2023 Nov 25;15(11):e49383. doi: 10.7759/cureus.49383. eCollection 2023 Nov.
6
[Case of clinically "aggressive" course of primary hyperparathyroidism, algorithm of differential diagnosis].[原发性甲状旁腺功能亢进症临床“侵袭性”病程病例,鉴别诊断算法]
Probl Endokrinol (Mosk). 2022 Sep 19;68(6):59-66. doi: 10.14341/probl13159.